BBB

BAFNA PHARMACEUTICALS LTD

No trades
See on Supercharts
Market capitalization
‪2.07 B‬INR
‪113.38 M‬INR
‪1.15 B‬INR
Beta (1Y)
0.12

About BAFNA PHARMACEUTICALS LTD

CEO
Bansilal Mahaveer C. Bafna
Headquarters
Chennai
Employees (FY)
588
Founded
1981
ISIN
INE878I01022
FIGI
BBG000V2CWK4
Bafna Pharmaceuticals Ltd. engages in the manufacture of drugs and medicines of life saving drugs. Its brand portfolio includes Raricap, Raricap Forte, Raricap L Suspension and Raricap Combi. The company was founded in 1981 and is headquartered in Chennai, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of BAFNAPH is 87.50 INR — it has increased by 0.57% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange BAFNA PHARMACEUTICALS LTD stocks are traded under the ticker BAFNAPH.
BAFNAPH stock is 3.39% volatile and has beta coefficient of 0.12. Check out the list of the most volatile stocks — is BAFNA PHARMACEUTICALS LTD there?
Yes, you can track BAFNA PHARMACEUTICALS LTD financials in yearly and quarterly reports right on TradingView.
BAFNAPH stock has fallen by 2.40% compared to the previous week, the month change is a 8.56% rise, over the last year BAFNA PHARMACEUTICALS LTD has showed a 1.74% increase.
BAFNAPH net income for the last quarter is ‪−29.42 M‬ INR, while the quarter before that showed ‪24.84 M‬ INR of net income which accounts for −218.46% change. Track more BAFNA PHARMACEUTICALS LTD financial stats to get the full picture.
Today BAFNA PHARMACEUTICALS LTD has the market capitalization of ‪2.07 B‬, it has increased by 7.48% over the last week.
No, BAFNAPH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BAFNAPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BAFNA PHARMACEUTICALS LTD stock right from TradingView charts — choose your broker and connect to your account.
BAFNAPH reached its all-time high on Dec 18, 2020 with the price of 233.55 INR, and its all-time low was 4.40 INR and was reached on Mar 2, 2020.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 588.00 employees. See our rating of the largest employees — is BAFNA PHARMACEUTICALS LTD on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BAFNA PHARMACEUTICALS LTD technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BAFNA PHARMACEUTICALS LTD stock shows the sell signal. See more of BAFNA PHARMACEUTICALS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BAFNA PHARMACEUTICALS LTD EBITDA is ‪158.45 M‬ INR, and current EBITDA margin is 13.63%. See more stats in BAFNA PHARMACEUTICALS LTD financial statements.